We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020-December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%-46.5%). We observed no increase in the seroprevalence trend after widespread school reopening. Seroprevalence estimates complement case-based cumulative incidence.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370852 | PMC |
| http://dx.doi.org/10.3201/eid2908.230471 | DOI Listing |
Publication Analysis
Top Keywords
sars-cov-2 seroprevalence
8
oregon usa
8
seroprevalence
5
pediatric sars-cov-2
4
seroprevalence oregon
4
usa november
4
november 2020-june
4
2020-june 2022
4
2022 estimated
4
estimated sars-cov-2
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!